News

Filter

Current filters:

nivolumabResearch

Bristol-Myers Ph III nivolumab trial stopped early on good results

Bristol-Myers Ph III nivolumab trial stopped early on good results

25-06-2014

Shares of US pharma major Bristol-Myers Squibb rose 2.6% to $49.55 in post-market trading on June 25,…

Bristol-Myers SquibbnivolumabOncologyPharmaceuticalResearch

Immunotherapies show promise for non-small cell lung cancer market

Immunotherapies show promise for non-small cell lung cancer market

13-06-2014

Immunotherapies have huge potential for the treatment of non-small cell lung cancer (NSCLC), with three…

BiotechnologyBristol-Myers SquibbMarkets & MarketingMerck & ConivolumabOncologypembrolizumabResearchRoche

ASCO 2014: Strong results for Bristol-Myers Yervoy, and combo with nivolumab

ASCO 2014: Strong results for Bristol-Myers Yervoy, and combo with nivolumab

02-06-2014

Among the latest important research results presented at the 2014 prestigious annual meeting of the American…

Bristol-Myers SquibbnivolumabOncologyPharmaceuticalResearchYervoy

Bristol-Myers and Incyte sign up to evaluate combo regimen of two immunotherapies

27-05-2014

US pharma major Bristol-Myers Squibb and Incyte Corp have set up a clinical trial collaboration to evaluate…

Bristol-Myers SquibbINCB24360IncyteLicensingnivolumabOncologyPharmaceuticalResearch

Bristol-Myers and Celldex to evaluate nivolumab and varlilumab combo

14-05-2014

US drug major Bristol-Myers Squibb and biotech firm Celldex Therapeutics have entered into a clinical…

BiotechnologyBristol-Myers SquibbCelldex TherapeuticsnivolumabOncologyResearchvarlilumab

Positive new data on Bristol-Myers’s clazakizumab and nivolumab

Positive new data on Bristol-Myers’s clazakizumab and nivolumab

29-10-2013

US drug major Bristol-Myers Squibb and partner privately-held Alder Biopharmaceuticals have presented…

Alder BiopharmaceuticalsAnti-Arthritics/RheumaticsBristol-Myers SquibbclazakizumabnivolumabOncologyPharmaceuticalResearch

Bristol-Myers' data on Yervoy and nivolumab causes a stir

17-05-2013

Release of abstracts of presentations to be made at the forthcoming49th Annual Meeting of the American…

Bristol-Myers SquibbnivolumabOncologyPharmaceuticalResearchYervoy

Back to top